{"id":"https://openalex.org/W3162391432","doi":null,"title":"Lipid Profile in Persons with Schizophrenia on Antipsychotic Medications in Uyo, South-South Nigeria","display_name":"Lipid Profile in Persons with Schizophrenia on Antipsychotic Medications in Uyo, South-South Nigeria","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3162391432","mag":"3162391432"},"language":"en","primary_location":{"id":"mag:3162391432","doi":null,"is_oa":true,"landing_page_url":"http://www.sapub.org/global/showpaperpdf.aspx?doi=10.5923/j.cmd.20211101.03","pdf_url":null,"source":{"id":"https://openalex.org/S2764650384","display_name":"Clinical Medicine and Diagnostics","issn_l":"2163-1433","issn":["2163-1433","2163-1441"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical Medicine and Diagnostics","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://www.sapub.org/global/showpaperpdf.aspx?doi=10.5923/j.cmd.20211101.03","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018614165","display_name":"Henry Effiong Jombo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry Effiong Jombo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Gabriel O. Ayoade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel O. Ayoade","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070448687","display_name":"Amadi Collins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amadi Collins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103973073","display_name":"Unyime Aniekpon Fabian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Unyime Aniekpon Fabian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000611155","display_name":"Enoobong K. Nkanga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Enoobong K. Nkanga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032522846","display_name":"Nkemakolam F. Ndionuka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nkemakolam F. Ndionuka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"11","issue":"1","first_page":"8","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8610000014305115},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9419999718666077},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.9010000228881836},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.9890000224113464},{"id":"https://openalex.org/keywords/metabolic-side-effects","display_name":"metabolic side effects","score":0.6899999976158142},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.8529999852180481},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8460000157356262},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.75},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9980000257492065},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.6520000100135803},{"id":"https://openalex.org/keywords/uyo-nigeria","display_name":"Uyo, Nigeria","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8840614557266235},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7792471647262573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6828780174255371},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6720637679100037},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6705962419509888},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.6123456358909607},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4679158329963684},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.45271551609039307},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.4301300644874573},{"id":"https://openalex.org/C2780320433","wikidata":"https://www.wikidata.org/wiki/Q3403879","display_name":"Weight gain","level":3,"score":0.42730197310447693},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.42691391706466675},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.42040833830833435},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3822783827781677},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3677881360054016},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.29743826389312744},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.18621426820755005}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3162391432","doi":null,"is_oa":true,"landing_page_url":"http://www.sapub.org/global/showpaperpdf.aspx?doi=10.5923/j.cmd.20211101.03","pdf_url":null,"source":{"id":"https://openalex.org/S2764650384","display_name":"Clinical Medicine and Diagnostics","issn_l":"2163-1433","issn":["2163-1433","2163-1441"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical Medicine and Diagnostics","raw_type":null}],"best_oa_location":{"id":"mag:3162391432","doi":null,"is_oa":true,"landing_page_url":"http://www.sapub.org/global/showpaperpdf.aspx?doi=10.5923/j.cmd.20211101.03","pdf_url":null,"source":{"id":"https://openalex.org/S2764650384","display_name":"Clinical Medicine and Diagnostics","issn_l":"2163-1433","issn":["2163-1433","2163-1441"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical Medicine and Diagnostics","raw_type":null},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1484975190","https://openalex.org/W1894553643","https://openalex.org/W1965785126","https://openalex.org/W1966928808","https://openalex.org/W1984541538","https://openalex.org/W2005286934","https://openalex.org/W2006752213","https://openalex.org/W2016706220","https://openalex.org/W2051108113","https://openalex.org/W2074863161","https://openalex.org/W2078807483","https://openalex.org/W2096635847","https://openalex.org/W2116404316","https://openalex.org/W2144334285","https://openalex.org/W2161045715","https://openalex.org/W2245231029","https://openalex.org/W2313223588","https://openalex.org/W2591078896","https://openalex.org/W4249825849"],"related_works":["https://openalex.org/W2400037972","https://openalex.org/W2591078896","https://openalex.org/W7099496495","https://openalex.org/W2090191759","https://openalex.org/W4312395432","https://openalex.org/W4401921342","https://openalex.org/W2070900370","https://openalex.org/W2016261361","https://openalex.org/W1986068310","https://openalex.org/W2156649968"],"abstract_inverted_index":{"Treatment":[0,133],"of":[1,31,64,72,98,105,115,119,129],"schizophrenia":[2,36,52],"with":[3,9,35,45,51,109,126,134,139],"antipsychotic":[4,38,116,130,135],"medications":[5,39,136],"may":[6],"be":[7],"associated":[8,44,138],"increased":[10,141],"risks":[11],"for":[12,55,143],"metabolic":[13],"disorders":[14],"such":[15],"as":[16],"weight":[17,122],"gain,":[18],"dyslipidemia,":[19],"and":[20,40,80,121],"insulin":[21],"resistance.":[22],"This":[23],"study":[24,101],"was":[25,94],"conducted":[26],"to":[27,89],"determine":[28],"the":[29,41,99],"prevalence":[30],"dyslipidaemia":[32],"in":[33,86,91,96],"patients":[34,49,87],"on":[37],"risk":[42,104,142],"factors":[43],"it.":[46],"Fifty":[47],"two":[48],"diagnosed":[50],"were":[53,68,83,124],"evaluated":[54],"lipid":[56],"profile":[57],"abnormalities.":[58],"Study":[59],"sample":[60],"had":[61],"a":[62],"mean":[63],"26.42\u00b110.8":[65],"years,":[66],"62.4%":[67],"males.":[69],"Mean":[70],"values":[71],"total":[73,100],"cholesterol":[74],"(TC),":[75],"low":[76],"density":[77],"lipoprotein":[78],"(LDL),":[79],"triglycerides":[81],"(TG)":[82],"significantly":[84,140],"higher":[85,108,125],"compared":[88],"subjects":[90],"controls.":[92],"Dyslipidaemia":[93],"present":[95],"26.9%":[97],"sample.":[102],"The":[103],"hyperlipidaemia":[106,120],"is":[107,137],"all":[110],"typical":[111],"or":[112],"atypical":[113],"class":[114],"medications.":[117],"Chances":[118],"gain":[123],"long":[127],"duration":[128],"medication":[131],"use.":[132],"hyperlipidaemia.":[144]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2021-05-24T00:00:00"}